Hypertension is recognized as the most important risk factor for heart failure with preserved ejection fraction. Please, treat to target!
Obstructive sleep apnea negatively impacts lipid levels, greatly increasing risk for CV disease and independent of obesity, according to the largest analysis of the link to date.
Hydralazine has one--and only one--robust evidence-based indication, this author says. So why is it still prescribed beyond that?
Is there a link between vitamin D deficiency and mortality in patients with heart failure? A new study may have the answer.
Medical nutrition therapy for hyperlipidemia management is widely recommended by clinical guidelines. Is it cost-effective?
A new study suggests that subclinical RV dysfunction may cause exercise-induced dyspnea in compensated subjects with PAH.
Treating patients with methamphetamine-associated PAH presents unique challenges including the pros and cons of placing venous access ports.
Early diagnosis of subtle brain damage in persons with hypertension has been elusive. Refined imaging technology may change that.
In a new study, increased waist-to-hip ratio was shown to have a significant link to risk of death in heart failure.
Does caffeine increase or decrease the risk of new onset AF? Find out with our T/F quiz on results of a new meta-analysis.